← Leaderboards
Paul Steven Bernstein
Utah State Higher Education System--University Of Utah
$10,561,575
Attributed
$10,772,898
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,127,117 · 10
By mechanism
R01$8,941,311 · 2
P30$4,134,485 · 4
R21$842,021 · 2
R29$209,300 · 1
M01$0 · 1
Top collaborators
- Mary Elizabeth Ruth Hartnett2 shared
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageRetinaTissuesLaboratoriesCarotenoidsBiochemistryAnimal ModelMaculaProteinsGrantClinical ResearchBasic ScienceAge Related Macular DegenerationPhysiologyDietIn VivoZeaxanthinLuteinBiochemicalInsightBlindnessRetinal DegenerationLightPhysiological
Grant awards (44)
University of Utah Core Vision Research Grant$762,910
P30 · FY2025 · EY · contact PI
Elucidating the Role of Very-long-chain Polyunsaturated Fatty Acids in Retinal Health and Disease$390,875
R01 · FY2025 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$385,000
R01 · FY2025 · EY · contact PI
Administrative Core$152,582
P30 · FY2025 · EY · contact PI
Elucidating the Role of Very-long-chain Polyunsaturated Fatty Acids in Retinal Health and Disease$30,000
R01 · FY2025 · EY · contact PI
University of Utah Core Vision Research Grant$610,000
P30 · FY2024 · EY · contact PI
Elucidating the Role of Very-long-chain Polyunsaturated Fatty Acids in Retinal Health and Disease$390,875
R01 · FY2024 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$385,000
R01 · FY2024 · EY · contact PI
Biochemistry$156,921
P30 · FY2024 · EY · contact PI
Elucidating the Role of Very-long-chain Polyunsaturated Fatty Acids in Retinal Health and Disease$30,000
R01 · FY2024 · EY · contact PI
University of Utah Core Vision Research Grant$610,000
P30 · FY2023 · EY · contact PI
Elucidating the Role of Very-long-chain Polyunsaturated Fatty Acids in Retinal Health and Disease$404,375
R01 · FY2023 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$384,792
R01 · FY2023 · EY · contact PI
A Phase 2 Study of the Value of Pre-symptomatic Genetic Risk Assessment for Age-Related Macular Degeneration$192,396
R21 · FY2023 · EY · contact PI
Biochemistry$156,921
P30 · FY2023 · EY · contact PI
University of Utah Core Vision Research Grant$610,000
P30 · FY2022 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$383,750
R01 · FY2022 · EY · contact PI
A Phase 2 Study of the Value of Pre-symptomatic Genetic Risk Assessment for Age-Related Macular Degeneration$230,250
R21 · FY2022 · EY · contact PI
Biochemistry$156,921
P30 · FY2022 · EY · contact PI
Core Vision Research Grant$151,309
P30 · FY2022 · EY · contact PI
University of Utah Core Vision Research Grant$610,000
P30 · FY2021 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$369,812
R01 · FY2021 · EY · contact PI
Biochemistry$156,921
P30 · FY2021 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$381,250
R01 · FY2020 · EY · contact PI
Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects$190,625
R21 · FY2020 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$381,250
R01 · FY2019 · EY · contact PI
Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects$228,750
R21 · FY2019 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$380,625
R01 · FY2018 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$378,437
R01 · FY2017 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$372,995
R01 · FY2016 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$365,534
R01 · FY2015 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$365,050
R01 · FY2014 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$372,916
R01 · FY2013 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$357,588
R01 · FY2011 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$372,488
R01 · FY2010 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$376,250
R01 · FY2009 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$368,725
R01 · FY2008 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$373,750
R01 · FY2007 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$291,974
R01 · FY2006 · EY · contact PI
Biochemistry and Pharmacology of the Macular Carotenoids$299,000
R01 · FY2005 · EY
Biochemistry and Pharmacology of the Macular Carotenoids$349,000
R01 · FY2004 · EY
BIOCHEMISTRY AND PHARMACOLOGY OF THE MACULAR CAROTENOIDS$104,650
R29 · FY2001 · EY
BIOCHEMISTRY AND PHARMACOLOGY OF THE MACULAR CAROTENOIDS$104,650
R29 · FY2000 · EY
AGE RELATED MACULAR DEGENERATION--PHOTODYNAMIC THERAPY$0
M01 · FY2000 · RR